Literature DB >> 21136826

Discovery of diagnostic serum biomarkers of gastric cancer using proteomics.

Katie Wing-Kei Lam1, Samuel Chun-Lap Lo.   

Abstract

Gastric cancer has significant morbidity and mortality worldwide and locally. Good prognosis relies on an early diagnosis. However, this remains a challenge due to the lack of specific and sensitive serum biomarkers for early detection. Hence, there is a constant search for these biomarkers for screening purposes. Proteomic profiling enables a new approach to the discovery of biomarkers in disease. This review presents recent attempts in search of gastric cancer serum biomarker using proteomics. Different methodologies and different types of samples were employed by different groups of researchers. Major difficulties were encountered in the discovery processes, including interference from abundant proteins and continuous changing serum proteomes from different individuals.
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2008        PMID: 21136826     DOI: 10.1002/prca.200780015

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  13 in total

1.  Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer.

Authors:  Hafeza Akter; Min Park; Oh-Seung Kwon; Eun Joo Song; Won-Sang Park; Min-Jung Kang
Journal:  Tumour Biol       Date:  2015-02-28

2.  High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer.

Authors:  A Ra Choi; Jun Chul Park; Jie-Hyun Kim; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Jae Bock Chung
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

3.  Serum peptidome profiling in patients with gastric cancer.

Authors:  Juan Yang; Yong-Chun Song; Cheng-Xue Dang; Tu-Sheng Song; Zhi-Gang Liu; You-Min Guo; Zong-Fang Li; Chen Huang
Journal:  Clin Exp Med       Date:  2011-07-08       Impact factor: 3.984

4.  Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).

Authors:  Juan Yang; Yong-Chun Song; Tu-Sheng Song; Xiao-Yan Hu; You-Min Guo; Zong-Fang Li; Cheng-Xue Dang; Chen Huang
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

Review 5.  Implementation of gastric cancer screening - the global experience.

Authors:  Mārcis Leja; Weicheng You; M Constanza Camargo; Hiroshi Saito
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-09-28       Impact factor: 3.043

6.  Proteomic analysis of endoscopically (endoscopic pancreatic function test) collected gastroduodenal fluid using in-gel tryptic digestion followed by LC-MS/MS.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Kathryn Repas; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  Proteomics Clin Appl       Date:  2010-09       Impact factor: 3.494

7.  Upregulation of plasma C9 protein in gastric cancer patients.

Authors:  Poh-Kuan Chong; Huiyin Lee; Marie Chiew Shia Loh; Lee-Yee Choong; Qingsong Lin; Jimmy Bok Yan So; Khong Hee Lim; Ross Andrew Soo; Wei Peng Yong; Siew Pang Chan; Duane T Smoot; Hassan Ashktorab; Khay Guan Yeoh; Yoon Pin Lim
Journal:  Proteomics       Date:  2010-09       Impact factor: 3.984

Review 8.  Noninvasive detection of gastric cancer.

Authors:  Qin-Si Wan; Kun-He Zhang
Journal:  Tumour Biol       Date:  2016-07-06

9.  Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.

Authors:  Jia Fan; Yi Huang; Inez Finoulst; Hung-Jen Wu; Zaian Deng; Rong Xu; Xiaojun Xia; Mauro Ferrari; Haifa Shen; Ye Hu
Journal:  Cancer Lett       Date:  2012-11-27       Impact factor: 8.679

10.  Mass Spectrometry-Based (GeLC-MS/MS) Comparative Proteomic Analysis of Endoscopically (ePFT) Collected Pancreatic and Gastroduodenal Fluids.

Authors:  Joao A Paulo; Vivek Kadiyala; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Clin Transl Gastroenterol       Date:  2012-05-03       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.